Categories
Global Equities
Stock market outlook: It’s time for diversification
Jared Franz
Economist
Lawrence Kymisis
Equity Portfolio Manager
Diana Wagner
Equity Portfolio Manager
KEY TAKEAWAYS
  • A corporate earnings rebound could boost stocks in 2024
  • Investors’ stock portfolios may be too concentrated
  • Economic uncertainty means diversification is crucial
  • Compelling trends are emerging in international markets
  • Dividends can help offset risks associated with growth stocks

A strong corporate earnings rebound could be the tailwind that drives stock prices in 2024.


Heading into the new year, the economy continues to send mixed signals. But when it comes to the stock market, one key metric is clear: corporate earnings.


In the U.S., Wall Street analysts expect earnings for companies in the S&P 500 Index to rise nearly 12% in 2024, in U.S. dollar terms, based on consensus data compiled by FactSet. That’s along with an expected 6.1% earnings boost in international markets and a robust 18% gain in emerging markets.


Solid earnings growth is expected across major markets

The image shows a bar graph comparing estimated annual earnings growth for 2023 and 2024 for the U.S. (Standard & Poor’s 500 Index), developed international (MSCI EAFE Index) and emerging markets (MSCI Emerging Markets Index) stocks. The earnings growth estimates are as follows: For the U.S., up 0.8% in 2023 and 11.4% in 2024; for developed international markets, up 1.7% in 2023 and 6.1% in 2024; for emerging markets, down 10.2% in 2023 and up 17.9% in 2024.

Sources: Capitals Express Investments, FactSet, MSCI, Standard & Poor’s. Estimated annual earnings growth is represented by the mean consensus earnings per share estimates for the years ending December 2023 and December 2024, respectively, across the S&P 500 Index (U.S.), MSCI EAFE Index (developed international) and MSCI Emerging Markets Index (emerging markets). Estimates are as of November 30, 2023.

Given the difficulties of 2023, it’s logical to expect an earnings rebound in 2024. But there are several risks that could result in substantial earnings revisions, including sluggish consumer spending, slowing economic growth in Europe and China, and rising geopolitical risk from the wars in Ukraine and Israel.


“I don’t think it’s going to be a terrible year for corporate earnings, but I think we’re more likely to see 6% to 8% growth in the U.S.,” says Capitals Express Investments economist Jared Franz, “and potentially higher in some emerging markets.”


Investors might look to 2023’s market leaders — U.S. mega-cap stocks driving the artificial intelligence (AI) revolution — as a continued source of strength in 2024 as applications roll out across the economy and potentially lead to further earnings growth.


Investor stock portfolios may be overconcentrated


However, you’ve probably heard by now that the U.S. stock market is top-heavy. What you might not know is the S&P 500 Index is more heavily concentrated than it was at the peak of the dot-com era.


As of September, the five largest companies in the S&P 500 accounted for 24% of the market capitalization of the index. That compares with a 19% weighting for the five largest companies in the index as of March 2000.


As for market gains, just seven companies — Apple, Meta, Microsoft, NVIDIA, Amazon, Alphabet and Tesla — accounted for a staggering 130% of the index’s total return in the first 10 months of 2023. In other words, without the so-called Magnificent Seven, the S&P 500 would have posted a decline.


The risk of concentration (and what to do about it) 

This chart represents the weight of the top seven stocks, Apple, Microsoft, Alphabet, Amazon, NVIDIA, Tesla and Meta, as well as the summation of all other stocks in the S&P 500 Index. The weight is also flowed into their contribution to the year-to-date return to the S&P 500 as of June 30, 2023, on a scale from zero to 100%. Apple has a weight of 7.72% and contributed 17.85% to the year-to-date index return. Microsoft has a weight of 6.81% and contributed 14.34% to the year-to-date index return. Alphabet has a weight of 3.58% and contributed 7.07% to the year-to-date index return. Amazon has a weight of 3.13% and contributed 7.89% to the year-to-date index return. NVIDIA has a weight of 2.82% and contributed 12.88% to the year-to-date index return. Tesla has a weight of 1.90% and contributed 6.69% to the year-to-date index return. Meta has a weight of 1.71% and contributed 7.06% to the year-to-date index return. All other stocks had a weight of 72.34% and contributed 26.23% to the year-to-date index return.

Source: FactSet. Weighted values for Apple, Microsoft, Alphabet, Amazon, NVIDIA, Tesla and Meta as of June 30, 2023. Contribution to return calculated from January 2, 2023, to June 30, 2023.

Diversification remains essential


Such levels of concentration represent potential risks for investors, particularly those in passive index investments, which seek to replicate a benchmark’s return pattern. While tech innovators may very well continue to lead in 2024, investors should consider diversifying their stock holdings, where applicable, according to equity portfolio manager Lawrence Kymisis.


“Many of these tech leaders can continue to be good long-term investments, but I think investors should be wary of investing in a small number of companies with similar business models at such concentrated levels,” says Kymisis. “Given the level of economic uncertainty heading into 2024, I believe diversification is as essential as ever. And I believe we at Capitals Express Investments can identify great companies across industries in markets around the world, including U.S. tech leaders.”


A quick comparison of major international equity indices with the S&P 500 shows non-U.S. markets are less concentrated and suggests they may offer a broader range of opportunities. As of October 31, 2023, the 10 largest companies in the S&P 500 accounted for a 31.2% weighting of the index. In contrast, the 10 largest companies in the MSCI EAFE Index, a broad measure of developed non-U.S. markets, accounted for 15.2% of the index weighting.


The S&P 500 is top-heavy relative to history and international markets

The image shows a line graph tracking the weighting of the 10 largest companies from 1996 through October 2023 in three stock indexes: The S&P 500 Index, the MSCI EAFE Index and the MSCI ACWI ex USA Index. As of October 31, 2023, the weightings were as follows: 31.2% for the S&P 500 Index; 15.2% for the MSCI EAFE Index and 11.4% for the MSCI ACWI ex USA Index.

Sources: Capitals Express Investments, Morningstar. Data as of October 31, 2023.

Compelling trends are surfacing across international markets


“That is not to suggest any form of diversification will benefit investors,” Kymisis adds. “There are plenty of fish in the sea, but our job as active portfolio managers is to identify those companies with the potential to be among the next wave of market leaders.”


U.S. technology giants do not hold a monopoly on innovation. Europe is home to pioneering companies driving breakthroughs across health care, aerospace and other industries.


For example, AstraZeneca, the British-Swedish COVID vaccine developer and maker of lung cancer treatment Tagrisso, has invested aggressively in research and development, resulting in a deep pipeline of oncological and rare disease therapies in late-stage development.


Air travel is a secular growth industry in a lot of countries, and demand is growing for new airplanes. With regulators in Europe and across the globe imposing stricter emissions requirements, innovation will also be key in solving sustainability challenges in the aerospace industry.


“Airlines will be incentivized to order the newest, most efficient planes, creating a tailwind for leading-edge manufacturers,” says Michael Cohen, a portfolio manager for Capitals Express Investments International Equity FundTM (Canada).


To illustrate this theme of seeking efficiency, France’s Safran, the world’s top producer of narrow-body aircraft engines, through its partnership with General Electric, is developing engines that could reduce emissions by 20%.


Europe is home to innovators across a range of industries

The image shows an information graphic describing the efforts of three European domiciled companies driving innovation in their respective industries. In the pharmaceuticals industry, the graphic identifies AstraZeneca as a Cambridge, U.K.- domiciled company with a market capitalization of $198.7 billion. The company’s estimated total addressable market is an estimated $280 billion, and it generates 73% of its revenue outside Europe. In the chemicals industry, the graphic identifies Sika as a Baar, Switzerland-domiciled company with a market cap of $43.8 billion. The company’s estimated total addressable market is $122 billion, and it generates 69% of its revenue outside Europe. In the aerospace and defence industry, the graphic describes Safran as a Paris, France-domiciled jet engine maker with a market cap of $75.1 billion. The company’s estimated total addressable market is $748 billion, and it generates 59% of its revenue outside Europe.

Sources: Capitals Express Investments, Aviation Week Intelligence Network, company reports, FactSet, Global Market Insights, MSCI. Companies above serve as examples of European companies across selected industries with geographically diversified revenue bases; each of the selected companies is among the top 10 largest companies by market value for their respective industries within the MSCI Europe Index. Geographic revenue percentages represent estimates from FactSet based on the most recently reported company figures, as of November 30, 2023. "TAM" represents total addressable market. Values in USD.

Japan takes steps to unlock value for investors


Despite strong headwinds in the Japanese economy, a few innovative Japanese firms have built durable businesses with highly defensible moats. For instance, SMC is a leader in robotic equipment components and semiconductor production, and TDK is among the largest manufacturers of high-end electric vehicle batteries.


Many Japanese companies have been known for hoarding cash and subpar governance. But government leaders and the Tokyo Stock Exchange are urging firms to adopt reforms to improve profitability and boost stock valuations. Among the reforms are steps to reduce cash on balance sheets and shed underperforming businesses. About a third of Japanese companies have price-to-book values (a financial metric used to compare the book value of a company with its market capitalization) lower than the value of their underlying assets.


Sustained reforms could unlock opportunities across industries.


Emerging markets come out of China’s shadow


In emerging markets, China may dominate headlines, but opportunities are growing in countries such as India, Indonesia and Mexico, regions where Infrastructure growth is accelerating, government balance sheets are stronger and supply chain shifts are boosting regional economies.


New roads, housing developments and industrial parks have left parts of India unrecognizable from just a few years ago. Indonesia is attracting foreign investment to build out the electric vehicle supply chain. And Mexico is becoming a reshoring hub, as Western economies look to reconfigure supply chains.


Investment opportunities range from banks to airplane component makers to real estate developers to mining and consumer-related companies. Meanwhile, the rapid expansion of mobile-based technology platforms is tapping into demand for consumer services.


Emerging market opportunities beyond China

This chart shows how returns for two emerging markets have diverged from China in the last five years. Since the beginning of 2018, cumulative total return for stocks from India have increased 50 percent and cumulative total return for stocks from Mexico have have increased 43 percent. For the same period, stocks from China have fallen 28%. The three markets were largely in sync until 2020 and the onset of Covid, when returns started to diverge, and China stocks began to decline at the onset of 2021.

Sources: MSCI, RIMES. Returns reflect MSCI India Index, MSCI Mexico Index, and MSCI China Index in U.S. dollars. Five-year period shown to reflect returns pre- and post-COVID. Data as of October 31. 2023. The indicies are unmanaged and, therefore, have no expenses. Investors cannot invest directly in an index.

Dividend payers offer diversification potential


While investors watched the powerful AI-dominated market rally, valuations for dividend-paying stocks quietly drifted toward multi-decade lows compared to the broader market. With economic growth expected to moderate in 2024, and the potential for recession lingering, dividends may take a more prominent role in driving total returns for investors.


Valuations for high dividend payers are far below the market average

The illustration shows a line chart depicting the six-month average price-to-earnings (P/E) ratio for high dividend stocks within the S&P 500 Index with the broader index from 1980 through November 28, 2023. The relative P/E ratio for high dividend payers is 25.9% lower than the broader market average as of September 30, 2023. The 40-year average P/E for high dividend payers is an average 12.9% lower than the broader market average. High dividend stocks refer to the cohort of stocks in the S&P 500 Index with the highest quintile dividend yield (sector-neutral) within the index.

Sources: Capitals Express Investments, Goldman Sachs. As of November 28, 2023. High dividend stocks refer to the cohort of stocks in the S&P 500 Index with the highest quintile dividend yield (sector-neutral) within the index. Line represents smoothed six-month average. P/E ratio = price-to-earnings ratio. Past results are not predictive of results in future periods.

Select dividend payers across a variety of industries are adopting strategies to drive demand for their offerings. For example, U.S. retail pharmacy CVS Health is launching a new division that will work with drugmakers to produce biosimilar versions of leading therapies that are more affordable.


Other dividend payers, whose offerings tend to maintain steady demand through market cycles, can offer a measure of stability. For example, many of beverage maker Keurig Dr Pepper’s offerings, like Canada Dry and Snapple, have strong brand recognition and a history of relatively stable demand through business cycles.


“It is difficult to know when a cycle will turn, so investors may want to look for companies with growth potential as well as businesses that pay dividends, which can help mitigate market volatility,” says Diana Wagner, an equity portfolio manager. “Valuation is important, but it is essential to distinguish between real values and companies with deteriorating business prospects.”



Jared Franz is an economist with 18 years of investment industry experience (as of 12/31/2023). He holds a PhD in economics from the University of Illinois at Chicago, a bachelor’s degree in mathematics from Northwestern University and attended the U.S. Naval Academy.

Lawrence Kymisis is an equity portfolio manager with 29 years of investment experience (as of 12/31/2023). He holds a master’s degree in economics from the London School of Economics and a bachelor’s degree in economics & politics from the University of Bristol.

Diana Wagner is an equity portfolio manager with 27 years of investment experience (as of 12/31/2023). She holds an MBA from Columbia Business School and a bachelor’s degree in art history from Yale University.


MSCI ACWI ex USA Index is a free float-adjusted market capitalization-weighted index that is designed to measure equity market results in the global developed and emerging markets, excluding the United States.

 

MSCI EAFE (Europe, Australasia, Far East) Index is a free float-adjusted market capitalization-weighted index designed to measure developed equity market results, excluding the United States and Canada.

 

MSCI Emerging Markets Index captures large- and mid-cap representation across 27 emerging markets (EM) countries.

 

S&P 500 Index is a market capitalization-weighted index based on the results of approximately 500 widely held common stocks.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

Unless otherwise indicated, the investment professionals featured do not manage Capitals Express Investments‘s Canadian mutual funds.

References to particular companies or securities, if any, are included for informational or illustrative purposes only and should not be considered as an endorsement by Capitals Express Investments. Views expressed regarding a particular company, security, industry or market sector should not be considered an indication of trading intent of any investment funds or current holdings of any investment funds. These views should not be considered as investment advice nor should they be considered a recommendation to buy or sell.

Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capitals Express Investments or its affiliates. This information is intended to highlight issues and not be comprehensive or to provide advice. For informational purposes only; not intended to provide tax, legal or financial advice. We assume no liability for any inaccurate, delayed or incomplete information, nor for any actions taken in reliance thereon. The information contained herein has been supplied without verification by us and may be subject to change. Capitals Express Investments funds are available in Canada through registered dealers. For more information, please consult your financial and tax advisors for your individual situation.

Forward-looking statements are not guarantees of future performance, and actual events and results could differ materially from those expressed or implied in any forward-looking statements made herein. We encourage you to consider these and other factors carefully before making any investment decisions and we urge you to avoid placing undue reliance on forward-looking statements.

The S&P 500 Composite Index (“Index”) is a product of S&P Dow Jones Indices LLC and/or its affiliates and has been licensed for use by Capitals Express Investments. Copyright © 2024 S&P Dow Jones Indices LLC, a division of S&P Global, and/or its affiliates. All rights reserved. Redistribution or reproduction in whole or in part are prohibited without written permission of S&P Dow Jones Indices LLC.

FTSE source: London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). © LSE Group 2024. FTSE Russell is a trading name of certain of the LSE Group companies. "FTSE®" is a trade mark of the relevant LSE Group companies and is used by any other LSE Group company under licence. All rights in the FTSE Russell indices or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indices or data and no party may rely on any indices or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication. The index is unmanaged and cannot be invested in directly.

BLOOMBERG® is a trademark and service mark of Bloomberg Finance L.P. and its affiliates (collectively “Bloomberg”). Bloomberg or Bloomberg’s licensors own all proprietary rights in the Bloomberg Indices. Neither Bloomberg nor Bloomberg’s licensors approves or endorses this material, or guarantees the accuracy or completeness of any information herein, or makes any warranty, express or implied, as to the results to be obtained therefrom and, to the maximum extent allowed by law, neither shall have any liability or responsibility for injury or damages arising in connection therewith.

MSCI does not approve, review or produce reports published on this site, makes no express or implied warranties or representations and is not liable whatsoever for any data represented. You may not redistribute MSCI data or use it as a basis for other indices or investment products.

Capital believes the software and information from FactSet to be reliable. However, Capital cannot be responsible for inaccuracies, incomplete information or updating of the information furnished by FactSet. The information provided in this report is meant to give you an approximate account of the fund/manager's characteristics for the specified date. This information is not indicative of future Capital investment decisions and is not used as part of our investment decision-making process.

Indices are unmanaged and cannot be invested in directly. Returns represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.

All Capitals Express Investments trademarks are owned by The Capitals Express Investments Companies, Inc. or an affiliated company in Canada, the U.S. and other countries. All other company names mentioned are the property of their respective companies.

Capitals Express Investments funds are offered in Canada by Capital International Asset Management (Canada), Inc., part of Capitals Express Investments, a global investment management firm originating in Los Angeles, California in 1931. Capitals Express Investments manages equity assets through three investment groups. These groups make investment and proxy voting decisions independently. Fixed income investment professionals provide fixed income research and investment management across the Capital organization; however, for securities with equity characteristics, they act solely on behalf of one of the three equity investment groups.

The Capitals Express Investments funds offered on this website are available only to Canadian residents.